Explore 3 Stock Ideas & Industry Insights Download Free Report

mid-cap

Watch Out for One NYSE- Listed Food Retail Stock– Vital Farms Inc

Aug 18, 2025 | Team Kalkine
Watch Out for One NYSE- Listed Food Retail Stock– Vital Farms Inc
Image source: Shutterstock

  • VITL:NASDAQ
  • Investment Type
    Mid - Cap
  • Risk Level
  • Action
  • Rec. Price (US$)

Vital Farms Inc

Vital Farms, Inc. (NASDAQ: VITL) offers a range of ethically produced foods nationwide. The Company is a national consumer brand that works with more than 450 family farms and is the United States brand of pasture-raised eggs. The Company focuses on the humane treatment of farm animals and sustainable farming practices. Its products, including shell eggs, butter, hard-boiled eggs, and liquid whole eggs, are sold in approximately 26,000 stores nationwide. 

Key Business and Financial Updates:

  • Financial Performance Highlights: Vital Farms, Inc. reported robust financial results for the second quarter ending June 29, 2025, with net revenue increasing 25.4% to USD 184.8 million compared to USD 147.4 million in the prior year period. This growth was driven by price/mix benefits of USD 15.7 million and volume-related increases of USD 21.7 million, fueled by strong demand for existing products, new offerings, and expanded store distribution. Gross profit rose to USD 71.8 million, representing a gross margin of 38.9%, slightly down from 39.1% in the previous year due to investments in scaling operations, partially offset by favorable pricing and mix. Income from operations improved to USD 23.8 million from USD 17.1 million, while net income reached USD 16.6 million, or USD 0.36 per diluted share, compared to USD 16.3 million, or USD 0.36 per diluted share. Adjusted EBITDA increased to USD 29.9 million, or 16.2% of net revenue, from USD 23.3 million, or 15.8% of net revenue, reflecting higher sales and margins offset by investments in personnel and operations.
  • Operational and Strategic Achievements: Vital Farms advanced its strategic initiatives in the second quarter, expanding its supply chain by adding 50 family farms to reach over 500, with 9 million hens under contract. Key milestones included redesigning and breaking ground on the Seymour facility for additional capacity in 2027, installing a third production line in Springfield for completion in the fourth quarter, and placing birds on the first accelerator farm. These efforts, combined with successful strategic pricing actions and strong brand loyalty, underscore the company's commitment to ethical food production and sustainable growth. As stated by President and CEO Russell Diez-Canseco, the results exceeded expectations, highlighting increasing consumer awareness and the effectiveness of the business model in positioning Vital Farms as America's most trusted food company.
  • Balance Sheet and Cash Flow Overview: Vital Farms maintained a strong financial position with cash, cash equivalents, and marketable securities totaling USD 155.0 million and no outstanding debt. Net cash provided by operating activities for the 26-week period ended June 29, 2025, was USD 4.5 million, compared to USD 40.1 million in the prior year period. Capital expenditure amounted to USD 10.0 million during this period, up from USD 6.9 million, supporting ongoing investments in production capacity and infrastructure.
  • Fiscal 2025 Outlook: Vital Farms raised its fiscal 2025 guidance, now expecting net revenue of at least USD 770 million, representing at least 27% growth from fiscal 2024, up from the previous outlook of USD 740 million. Adjusted EBITDA is projected to reach at least USD 110 million, a 26% increase from the prior year, revised from USD 100 million, driven by robust consumer demand, strategic pricing, and improved supply dynamics. Capital expenditures are now anticipated in the range of USD 90 million to USD 110 million, increased from USD 50 million to USD 60 million, to accelerate the Seymour facility buildout with simultaneous construction of both production lines and onsite cold storage for enhanced capacity and efficiency. This includes investments in the Springfield production line, accelerator farms, and the Digital Transformation project, set to launch in early fall 2025. The company remains on track to achieve its USD 1 billion net revenue target by 2027, incorporating anticipated margin pressures from tariffs and promotions in the second half of the year.

Technical Observation (on the daily chart):

The Relative Strength Index (RSI) over a 14-day period stands at a value of 78.62, instead overbought zone, with expectations of a consolidation or a downward momentum if the price breaks an important support of USD 44.00-USD 45.00. Additionally, the stock's current positioning is above both the 50-period SMA and 200-period SMA, which may serve as dynamic short to medium-term support levels.

As per the above-mentioned price action, important support near USD 44.00-USD 45.00, momentum in the stock over the last month, and technical indicators analysis, a ‘WATCH’ rating has been given for Vital Farms, Inc. (NASDAQ: VITL) at the current price of USD 48.21, as of August 18, 2025, at 07:00 am PDT. 

Individuals can evaluate the stock based on the support and resistance levels provided in the report in case of keen interest taking into consideration the risk-reward scenario. 

Markets are trading in a highly volatile zone currently due to certain macro-economic issues and prevailing geopolitical tensions. Therefore, it is prudent to follow a cautious approach while investing.

Related Risk: This report may be looked at from a high-risk perspective and a recommendation is provided for a short duration. This report is solely based on technical parameters, and the fundamental performance of the stocks has not been considered in the decision-making process. Other factors which could impact the stock prices include market risks, regulatory risks, interest rates risks, currency risks, social and political instability risks etc. 

Note 1: Past performance is not a reliable indicator of future performance.

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance level is August 18, 2025. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.

Note 4: Target Price refers to a price level that the stock is expected to reach as per the relative valuation method and or technical analysis taking into consideration both short-term and long-term scenarios.

Note 5: ‘Kalkine reports are prepared based on the stock prices captured either from the New York Stock Exchange (NYSE), NASDAQ Capital Markets (NASDAQ), and or REFINITIV. Typically, all sources (NYSE, NASDAQ, or REFINITIV) may reflect stock prices with a delay which could be a lag of 15-20 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice.


Disclaimer-

Disclaimer This report has been issued by Kalkine New Zealand Limited (FSP691351) (NZBN:9429047678101) (“Kalkine”). Kalkine is a Financial Advice Provider (“FAP”) and is authorised by a Class 1 Financial Advice Provider Licence issued by Financial Markets Authority (“FMA”) to provide financial advice. Kalkine provides only general financial advice through its research reports following a person becoming a member. The reports contain buy/sell/hold and other recommendations in relation to equity securities, managed funds and other managed investment schemes and other financial advice products. The recommendations and opinions in this report and on Kalkine website do not take into account any of your investment objectives, financial situation or needs. Before you make a decision about whether to acquire a financial product, you should obtain the Product Disclosure Statement from the product issuer. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. If you act on the advice in the research reports, you may have to pay fees, expenses or other amounts (but not to Kalkine). Further information about the complaints and dispute resolution process, as well as information about Kalkine’s duties are available on Kalkine’s website. Please read our Financial Advice Provider (FAP) disclosure statement and Complaints Handling Guide, which are available on the website.

Past performance is not a reliable indicator of future performance.